Join our expert panel for an in-depth discussion on the advancements in DMTs for Alzheimer’s disease.
Part One: Prof. Chris Chen presents a case study of a 69-year-old right-handed female, highlighting the integration of revised guidelines into her treatment plan. The patient's symptoms were managed using anti-amyloid therapy, notably without the occurrence of ARIA.
Part Two: Prof. Chris Chen is joined by Prof. Ralph Martins to delve deeper into the case study. They explore the Revised Diagnostic and Staging Criteria for Alzheimer’s Disease, the impact of blood-based biomarkers on Alzheimer's diagnosis, patient education and genetic counselling.